In the world economic growth, the Atropine Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Atropine market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Atropine market size will be further expanded, we expect that by 2024, The market size of the Atropine will reach XXX million $.
Atropine Market Overview
Atropine is a medication used to treat certain types of nerve agent and pesticide poisonings. It is also used to treat a slow heart rate and decreased saliva production. Atropine is administered intravenously or by injection into a muscle. Moreover, eye drops are also available to treat early amblyopia and uveitis. The global atropine market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global atropine market is expected to witness significant growth during the forecast period, owing to increasing incidents of pesticide poisoning across the world.
Atropine Market Driver
Increasing incidents of pesticide poisoning and uveitis worldwide is expected to drive growth of the global atropine market during the forecast period. According to the United Nations (UN), around 200,000 people die each year from pesticide poisoning. Furthermore, according to Uveitis.org, in the U.S., the prevalence of uveitis is around 38 cases per 100,000 population and incidence of 15 cases per 100,000 population. Atropine is majorly used in the treatment of both pesticide poisoning and uveitis. For pesticide poisoning, atropine administered intravenously, while for uveitis, it is administered via eye drops. Hence, these factors are expected to drive growth of the global atropine market in the near future. Moreover, growing use of atropine in saliva production during surgery and in some types of slow heart rate are expected to propel the global atropine market growth over the forecast period.
Atropine Market Restraint
Side-effects caused due to high dosage of atropine such as drowsiness, coma, convulsions, and stupor are expected to hinder the global atropine market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global atropine market during the forecast period. This is owing to robust healthcare facilities and growing expenditure in the healthcare industry across the region. Moreover, Asia Pacific is expected to register a lucrative growth rate over the forecast period, owing to rising awareness regarding the benefits of atropine in the region.
Competitive Section
Key companies involved in the global atropine market are C²PHARMA, Wuhan Senwayer Century, RESONANCE LABORATORIES, Hangzhou Vega, ROLABO OUTSOURCING, Katsura Chemical, Minsheng Group, SAURAV CHEMICALS, CR Double-Crane, Alchem International, HENAN PURUI, and Albany Molecular Research.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
✑ C²PHARMA
✑ RESONANCE LABORATORIES
✑ ROLABO OUTSOURCING
✑ Minsheng Group
✑ CR Double-Crane
✑ HENAN PURUI
✑ Albany Molecular Research
✑ Alchem International
✑ SAURAV CHEMICALS
✑ Katsura Chemical
✑ Hangzhou Vega
✑ Wuhan senwayer century
Section 4: Region Segmentation
✑ North America Country (United States, Canada)
✑ South America
✑ Asia Country (China, Japan, India, Korea)
✑ Europe Country (Germany, UK, France, Italy)
✑ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation:
✑ Injection
✑ Drop
✑ Gel
Industry Segmentation:
✑ Gastrointestinal
✑ Ophthalmology
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
